🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/12/1976 | 1,78 | 1,80 | 1,76 | 1,79 | +0,74% | 2,23% | 1.973.174 |
| 23/12/1976 | 1,79 | 1,79 | 1,76 | 1,78 | -0,74% | 1,66% | 2.437.229 |
| 22/12/1976 | 1,79 | 1,81 | 1,79 | 1,79 | +0,18% | 1,30% | 4.565.088 |
| 21/12/1976 | 1,76 | 1,79 | 1,74 | 1,79 | +1,88% | 2,64% | 2.905.056 |
| 20/12/1976 | 1,77 | 1,77 | 1,76 | 1,76 | -0,56% | 0,94% | 1.361.981 |
| 17/12/1976 | 1,75 | 1,78 | 1,74 | 1,77 | +0,94% | 2,28% | 2.327.818 |
| 16/12/1976 | 1,75 | 1,76 | 1,73 | 1,75 | -0,19% | 1,51% | 2.063.722 |
| 15/12/1976 | 1,76 | 1,78 | 1,75 | 1,75 | -0,19% | 2,07% | 3.648.298 |
| 14/12/1976 | 1,72 | 1,76 | 1,71 | 1,76 | +2,32% | 3,09% | 2.456.093 |
| 13/12/1976 | 1,75 | 1,75 | 1,72 | 1,72 | -1,71% | 1,90% | 1.852.445 |
| 10/12/1976 | 1,76 | 1,76 | 1,74 | 1,75 | -0,56% | 1,51% | 1.139.386 |
| 09/12/1976 | 1,76 | 1,78 | 1,75 | 1,76 | -0,37% | 1,88% | 1.539.302 |
| 08/12/1976 | 1,75 | 1,77 | 1,75 | 1,76 | +1,14% | 1,32% | 2.795.645 |
| 07/12/1976 | 1,78 | 1,78 | 1,74 | 1,74 | -1,87% | 2,06% | 1.580.803 |
| 06/12/1976 | 1,74 | 1,79 | 1,74 | 1,78 | +3,08% | 2,47% | 2.708.870 |
| 03/12/1976 | 1,67 | 1,74 | 1,66 | 1,72 | +3,18% | 4,37% | 3.625.661 |
| 02/12/1976 | 1,69 | 1,70 | 1,66 | 1,67 | -1,18% | 2,16% | 3.384.202 |
| 01/12/1976 | 1,69 | 1,69 | 1,68 | 1,69 | -0,39% | 0,78% | 2.701.325 |
| 30/11/1976 | 1,72 | 1,73 | 1,70 | 1,70 | -1,54% | 1,92% | 2.029.766 |
| 29/11/1976 | 1,75 | 1,75 | 1,72 | 1,72 | -1,33% | 2,09% | 1.886.400 |
| 26/11/1976 | 1,76 | 1,76 | 1,75 | 1,75 | -0,75% | 0,94% | 1.810.944 |
| 24/11/1976 | 1,78 | 1,78 | 1,75 | 1,76 | -0,93% | 1,49% | 1.539.302 |
| 23/11/1976 | 1,79 | 1,79 | 1,76 | 1,78 | -1,29% | 1,30% | 2.244.816 |
| 22/11/1976 | 1,76 | 1,80 | 1,76 | 1,80 | +2,07% | 2,26% | 2.478.730 |
| 19/11/1976 | 1,81 | 1,82 | 1,73 | 1,76 | -2,39% | 4,59% | 3.138.970 |
| 18/11/1976 | 1,83 | 1,85 | 1,80 | 1,81 | -1,27% | 2,35% | 2.146.723 |
| 17/11/1976 | 1,84 | 1,84 | 1,81 | 1,83 | -0,72% | 1,26% | 2.539.094 |
| 16/11/1976 | 1,87 | 1,87 | 1,83 | 1,84 | -1,42% | 2,13% | 1.644.941 |
| 15/11/1976 | 1,84 | 1,87 | 1,82 | 1,87 | +1,80% | 2,52% | 1.335.571 |
| 12/11/1976 | 1,84 | 1,84 | 1,80 | 1,84 | -0,54% | 1,80% | 2.101.450 |